Just a moment, the page is loading...
Browse ALL STUDIES
Keyword Search
View All Selected
Clear All
Login / Create Account
Login
Create Account
Home
About Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Data Sponsors
Researchers
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
Help/Contact Us
UCB-AKS001
Study Sponsor :
UCB
Study Title
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Medicine or Vaccine (generic name)
Certolizumab Pegol
Sponsor Identification Number
AKS001
Trial Registry Identification Number(#'s)
NCT01087762
Medical Condition
Axial Spondyloarthritis
Phase
Phase 3
Link to study details on the UCB Clinical Study Register
https://www.ucb.com/clinical-studies/Clinical-studies-index
Link to study details on ClinicalTrials.gov (if available)
https://clinicaltrials.gov/ct2/show/study/NCT01087762?term=nCT01087762&rank=1
Link to study details on EudraCT (if available)
Datasets and Documents Available for this Study
Raw dataset
Annotated case report form
Dataset specifications
Protocol with any amendments
Analysis-ready dataset
Reporting and analysis plan
Clinical study report
Ready to Share
Additional information about the data and documents available for this study
AD and ADaM are available for Analysis and Reporting Dataset
Datasets are available in English only
Date Added to this Site
July 2014
© 2025 ideaPoint. All Rights Reserved.
Powered by ideaPoint.
Help
Privacy Policy
Cookie Policy
Help and Resources